Novare Capital Management’s Invesco BulletShares 2031 Corporate Bond ETF BSCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Buy
221,568
+18,723
+9% +$308K 0.26% 73
2026
Q1
$3.34M Buy
202,845
+8,696
+4% +$145K 0.26% 72
2025
Q4
$3.24M Buy
194,149
+15,643
+9% +$261K 0.24% 73
2025
Q3
$2.98M Buy
178,506
+26,245
+17% +$436K 0.23% 75
2025
Q2
$2.52M Buy
152,261
+8,730
+6% +$142K 0.2% 85
2025
Q1
$2.34M Buy
143,531
+4,447
+3% +$71.9K 0.2% 83
2024
Q4
$2.23M Buy
139,084
+13,295
+11% +$217K 0.19% 87
2024
Q3
$2.1M Buy
125,789
+12,444
+11% +$204K 0.18% 87
2024
Q2
$1.81M Buy
113,345
+7,056
+7% +$112K 0.16% 90
2024
Q1
$1.71M Buy
106,289
+19,980
+23% +$322K 0.15% 93
2023
Q4
$1.42M Buy
86,309
+46,528
+117% +$723K 0.14% 96
2023
Q3
$607K Buy
+39,781
New +$624K 0.07% 118

Other funds holding BSCV

Novare Capital Management's BSCV Position: Q2 2026 in Review

Novare Capital Management increased its Invesco BulletShares 2031 Corporate Bond ETF (BSCV) stake by 9.2% in Q2 2026, buying an estimated $308K and bringing the position to 221,568 shares worth $3.63M. The position accounts for 0.26% of the portfolio, ranked #73.

Novare Capital Management first reported a position in BSCV in Q3 2023 and has held it in 12 quarters since. 220 funds tracked by Wall St. Rank hold BSCV as of Q2 2026.

  • Novare Capital Management held 221,568 shares of Invesco BulletShares 2031 Corporate Bond ETF worth $3.63M as of Q2 2026.
  • Novare Capital Management bought 18,723 Invesco BulletShares 2031 Corporate Bond ETF shares in Q2 2026, an estimated $308K.
  • Invesco BulletShares 2031 Corporate Bond ETF made up 0.26% of Novare Capital Management's portfolio in Q2 2026, its #73 holding.
  • Novare Capital Management first reported a position in Invesco BulletShares 2031 Corporate Bond ETF in Q3 2023 and has held it in 12 quarters since.
  • 220 funds tracked by Wall St. Rank held Invesco BulletShares 2031 Corporate Bond ETF as of Q2 2026.

Based on Novare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.